Cancer Drug Costs Up In Part D With Expanded Use And Price Growth

04 Jan 2016

Medicare 'Dashboard' spotlights costliest drugs in Part D and Part B programs to help inform public debate around controlling spending increases.

Medicare Part D spending for the five costliest oncology drugs covered by the program rose between 7% and 93% in 2014, based on an analysis of data in the online Medicare Drug Spending Dashboard tool recently unveiled by the Centers for Medicare and Medicaid Services.

The increase in costs was driven by a combination of broader use of all but one of the drugs and...